The medical systems division of Japanese industrial conglomerate Shimadzu posted revenue growth of 3.6% in the company's second quarter, although the business also recorded an operating loss for the period.
For the quarter (end-June 30), Shimadzu's medical division had sales of 10.377 billion yen ($134.4 million U.S.), while posting a quarterly loss of 463 million yen ($6 million U.S.).
The company said that sales of medical systems are strong in China due to investment by the government in healthcare, while sales of radiography systems are also strong in other parts of Asia. On the other hand, sales in Europe are slow due to fiscal austerity measures in European Union countries.
